340 related articles for article (PubMed ID: 32146898)
21. Muscle Mass and Direct Oral Anticoagulant Activity in Older Adults With Atrial Fibrillation.
Bendayan M; Mardigyan V; Williamson D; Chen-Tournoux A; Eintracht S; Rudski L; MacNamara E; Blostein M; Afilalo M; Afilalo J
J Am Geriatr Soc; 2021 Apr; 69(4):1012-1018. PubMed ID: 33432589
[TBL] [Abstract][Full Text] [Related]
22. Analysis of Oral Anticoagulant Dosing and Adherence to Therapy Among Patients With Nonvalvular Atrial Fibrillation.
Rymer JA; Chiswell K; Young L; Chiu A; Liu L; Webb L; Carlisle M; Friedman D; Wang TY
JAMA Netw Open; 2023 Jun; 6(6):e2317156. PubMed ID: 37285155
[TBL] [Abstract][Full Text] [Related]
23. Apixaban for prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: The PAROS cross-sectional study of routine clinical practice.
Falissard B; Picard F; Mahe I; Hanon O; Touzé E; Danchin N; Lamy FX; Ricci L; Steg PG
Arch Cardiovasc Dis; 2019; 112(6-7):400-409. PubMed ID: 31014991
[TBL] [Abstract][Full Text] [Related]
24. Mortality in Patients With Atrial Fibrillation Receiving Nonrecommended Doses of Direct Oral Anticoagulants.
Camm AJ; Cools F; Virdone S; Bassand JP; Fitzmaurice DA; Arthur Fox KA; Goldhaber SZ; Goto S; Haas S; Mantovani LG; Kayani G; Grierson Turpie AG; Antoon Verheugt FW; Kakkar AK;
J Am Coll Cardiol; 2020 Sep; 76(12):1425-1436. PubMed ID: 32943160
[TBL] [Abstract][Full Text] [Related]
25. Physical, cognitive, and psychosocial conditions in relation to anticoagulation satisfaction among elderly adults with atrial fibrillation: The SAGE-AF study.
Wang W; Saczynski J; Lessard D; Mailhot T; Barton B; Waring ME; Sogade F; Hayward R; Helm R; McManus DD
J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2508-2515. PubMed ID: 31515920
[TBL] [Abstract][Full Text] [Related]
26. Modification of In-Hospital Recommendation and Prescription of Anticoagulants for Secondary Prevention of Stroke after Launch of Direct Oral Anticoagulants and Change of National Guidelines.
Gronemann C; Hause S; Assmann A; Neumann J; Schreiber S; Heinze HJ; Goertler M
Cerebrovasc Dis; 2020; 49(4):412-418. PubMed ID: 32756054
[TBL] [Abstract][Full Text] [Related]
27. Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation.
Franchi C; Antoniazzi S; Proietti M; Nobili A; Mannucci PM;
Br J Clin Pharmacol; 2018 Sep; 84(9):2010-2019. PubMed ID: 29745441
[TBL] [Abstract][Full Text] [Related]
28. Clinical Outcomes of Off-Label Dosing of Direct Oral Anticoagulant Therapy Among Japanese Patients With Atrial Fibrillation Identified From the SAKURA AF Registry.
Murata N; Okumura Y; Yokoyama K; Matsumoto N; Tachibana E; Kuronuma K; Oiwa K; Matsumoto M; Kojima T; Hanada S; Nomoto K; Arima K; Takahashi F; Kotani T; Ikeya Y; Fukushima S; Itoh S; Kondo K; Chiku M; Ohno Y; Onikura M; Hirayama A;
Circ J; 2019 Mar; 83(4):727-735. PubMed ID: 30726797
[TBL] [Abstract][Full Text] [Related]
29. Appropriateness of Dabigatran and Rivaroxaban Prescribing in Qatar: A 5-Year Experience.
Elewa H; El-Makaty H; Ali Z
J Cardiovasc Pharmacol Ther; 2018 Mar; 23(2):155-161. PubMed ID: 28978236
[TBL] [Abstract][Full Text] [Related]
30. Creatinine clearance and inappropriate dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation.
Yagi N; Suzuki S; Arita T; Otsuka T; Semba H; Kano H; Matsuno S; Kato Y; Uejima T; Oikawa Y; Yajima J; Matsuhama M; Yamashita T
Heart Vessels; 2020 Jan; 35(1):110-117. PubMed ID: 31222552
[TBL] [Abstract][Full Text] [Related]
31. Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation.
Giustozzi M; Agnelli G; Quattrocchi S; Acciarresi M; Alberti A; Caso V; Vedovati MC; Venti M; Paciaroni M
Cerebrovasc Dis Extra; 2020; 10(2):44-49. PubMed ID: 32375143
[TBL] [Abstract][Full Text] [Related]
32. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a "Real-world" Nationwide Registry: Insights From the FANTASIIA Study.
Ortiz MR; Muñiz J; Esteve-Pastor MA; Marín F; Roldán I; Cequier A; Martínez-Sellés M; Saldivar HG; Bertomeu V; Anguita M
J Cardiovasc Pharmacol Ther; 2020 Jul; 25(4):316-323. PubMed ID: 32228180
[TBL] [Abstract][Full Text] [Related]
33. Appropriateness of inpatient dosing of direct oral anticoagulants for atrial fibrillation.
Li RJ; Caughey GE; Shakib S
J Thromb Thrombolysis; 2022 Feb; 53(2):425-435. PubMed ID: 34302286
[TBL] [Abstract][Full Text] [Related]
34. Flaws in Anticoagulation Strategies in Patients With Atrial Fibrillation at Hospital Discharge.
Kartas A; Samaras A; Vasdeki D; Dividis G; Fotos G; Paschou E; Forozidou E; Tsoukra P; Kotsi E; Goulas I; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
J Cardiovasc Pharmacol Ther; 2019 May; 24(3):225-232. PubMed ID: 30599759
[TBL] [Abstract][Full Text] [Related]
35. Effect of Renal Function on Dosing of Non-Vitamin K Antagonist Direct Oral Anticoagulants Among Patients With Nonvalvular Atrial Fibrillation.
Shrestha S; Baser O; Kwong WJ
Ann Pharmacother; 2018 Feb; 52(2):147-153. PubMed ID: 28856898
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of patients initiated on edoxaban in Europe: baseline data from edoxaban treatment in routine clinical practice for patients with atrial fibrillation (AF) in Europe (ETNA-AF-Europe).
De Caterina R; Kelly P; Monteiro P; Deharo JC; de Asmundis C; López-de-Sá E; Weiss TW; Waltenberger J; Steffel J; de Groot JR; Levy P; Bakhai A; Zierhut W; Laeis P; Kerschnitzki M; Reimitz PE; Kirchhof P;
BMC Cardiovasc Disord; 2019 Jul; 19(1):165. PubMed ID: 31299906
[TBL] [Abstract][Full Text] [Related]
37. Inappropriate direct oral anticoagulant dosing in atrial fibrillation patients is associated with prescriptions for outpatients rather than inpatients: a single-center retrospective cohort study.
Miyazaki M; Matsuo K; Uchiyama M; Nakamura Y; Sakamoto Y; Misaki M; Tokura K; Jimi S; Okamura K; Adachi S; Yamamoto T; Shirai K; Urata H; Imakyure O
J Pharm Health Care Sci; 2020; 6():2. PubMed ID: 32071730
[TBL] [Abstract][Full Text] [Related]
38. Geriatric Conditions and Prescription of Vitamin K Antagonists vs. Direct Oral Anticoagulants Among Older Patients With Atrial Fibrillation: SAGE-AF.
McManus DD; Kiefe C; Lessard D; Waring ME; Parish D; Awad HH; Marino F; Helm R; Sogade F; Goldberg R; Hayward R; Gurwitz J; Wang W; Mailhot T; Barton B; Saczynski J
Front Cardiovasc Med; 2019; 6():155. PubMed ID: 31737647
[No Abstract] [Full Text] [Related]
39. Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.
Howard M; Lipshutz A; Roess B; Hawes E; Deyo Z; Burkhart JI; Moll S; Shilliday BB
J Thromb Thrombolysis; 2017 Feb; 43(2):149-156. PubMed ID: 27757787
[TBL] [Abstract][Full Text] [Related]
40. Frailty, Cognitive Impairment, and Anticoagulation Among Older Adults with Nonvalvular Atrial Fibrillation.
Mailhot T; McManus DD; Waring ME; Lessard D; Goldberg R; Bamgbade BA; Saczynski JS
J Am Geriatr Soc; 2020 Dec; 68(12):2778-2786. PubMed ID: 32780497
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
